Andrew Emerson
Known title: EVP, CFO and TreasurerCIK: 0002058587
Associated companies
Transaction History
| IDXX | ▲ Buy | Option Exercise | 265 | $47K | 8/20/2026 | View on chart |
| IDXX | ▼ Sell | Tax Withholding | 86 | $0 | 8/20/2026 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 61 | $0 | 2/14/2026 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 94 | $0 | 2/14/2026 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 42 | $0 | 2/14/2026 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 194 | $0 | 2/14/2026 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 65 | $0 | 2/14/2026 | View on chart |
| IDXX | ▼ Sell | Tax Withholding | 123 | $77K | 2/14/2026 | View on chart |
| IDXX | ▲ Buy | Option Exercise | 1,849 | $262K | 8/7/2025 | View on chart |
| IDXX | ▼ Sell | Tax Withholding | 402 | $261K | 8/7/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
KeyBanc initiates IDEXX coverage with Sector Weight rating
KeyBanc has started covering IDEXX Laboratories, assigning it a Sector Weight rating. This move adds to analyst attention as investors look ahead to the company's upcoming Q3 2026 earnings report. The stock is currently trading near its 52-week high, reflecting strong recent performance.
KeyBanc initiates IDEXX coverage with Sector Weight rating. KeyBanc has started covering IDEXX Laboratories, assigning it a Sector Weight rating. This move adds to analyst attention as investors look ahead to the company's upcoming Q3 2026 earnings report. The stock is currently trading near its 52-week high, reflecting strong recent performance.